IndraLab

Statements

Salsalate inhibits IKBKB. 1 / 1

| 1

reach

"Clinical studies have found that Salsalate, a prodrug of salicylate which suppresses inflammation, attenuates IKKbeta and NF-kappaB activity, improves glycemic control in patients with type-2 diabetes, [XREF_BIBR] and alleviates IR."

28025032

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Salsalate inhibits IKBKB. 1 / 1

INDRA sources:

Databases

Reading